Transferrin is an iron-transport protein which possesses N-glycans at Asn432 and Asn630 in humans. Transferrin glycoforms Tf-1 and Tf-2, previously identified in human cerebrospinal fluid, are defined as the lower and upper bands in gel electrophoresis, respectively. Importantly, the Tf-2/Tf-1 ratio is raised in idiopathic normal pressure hydrocephalus patients and is useful as a clinical marker. In order to gain insight into the relationship between transferrin glycoform and biological function, we performed comparative characterization of Tf-1, Tf-2 and serum transferrin (sTf). Mass spectrometric analyses confirmed that Tf-2 is modified with disialylated biantennary glycans at both of the two N-glycosylation sites, which are similar to the N-glycans of sTf. On the other hand, Tf-1 is site-specifically modified: Asn630 has biantennary agalacto-complex-type glycan with bisecting N-acetylglucosamine (GlcNAc) and core fucose while Asn432 is modified with complex/high mannose-type glycans and possibly single GlcNAc. Size exclusion chromatography and fluorescence correlation spectroscopy analysis revealed that the hydration volume of Tf-1 is slightly smaller than that of sTf. Our striking finding is that Tf-1 has an exposed hydrophobic surface as monitored by the fluorescence intensity and wavelength of a hydrophobic probe, 1-anilino-8-naphthalene sulfonate, whereas Tf-2 does not. These results suggest that the different N-glycan structure of Tf-1 lowers the apparent hydration volume and reveals a patch of hydrophobic surface on transferrin which is otherwise covered with sialoglycan in sTf and Tf-2. The carbohydrate deficiency in certain pathological conditions may also expose hydrophobic surface which may modulate the function and/or stability of transferrin.
Introduction
Transferrin (Tf ) proteins are a family of non-heme irontransport glycoproteins with molecular weights of 74 kDa and are found in multicellular organisms from cockroaches to humans. Serum Tf (sTf ) delivers iron to cells by a receptormediated, pH-dependent process (Qian et al. 2002) . Mature human sTf, without the signal peptide, is a single polypeptide chain of 679 amino acid residues with two N-glycosylation sites at Asn432 and Asn630 ( Figure 1A ). It consists of two globular domains, the N-and C-terminal domains (or N-and C-lobes), connected by a short-linker peptide (Bailey et al. 1988; Kurokawa et al. 1995) (Figure 1B ). They have similar 3D structures and are further divided into two subdomains (designated N1, N2 and C1, C2 subdomains). A single iron ion binds between two subdomains. Binding and release of iron result in a large conformational change in which two subdomains in each lobe close or open with a rigid twisting motion around a hinge region.
sTf is modified with bi-or triantennary complex-type glycans harboring a varying number of terminal N-acetylneuraminic acid (NeuAc) residues, resulting in a heterogeneous population of sTf glycoforms (de Jong et al. 1992; Coddeville et al. 1998) . Abnormal sTf isoforms, commonly referred to as carbohydratedeficient transferrin, are the most reliable and sensitive marker for congenital disorders of glycosylation (CDG). Major abnormal sTf isoforms in CDG lack one or two whole N-glycan chains (Wada et al. 1992; Yamashita et al. 1993 ). The absence of N-glycans or their defective elongation decreases the number of sialic acid residues on the glycans, thus changing the number of negative charges and the isoelectric point. Such sTf glycoforms are clinically detected using isoelectric focusing, ion-exchange chromatography and mass spectrometric analysis. Altered glycan structure of Tf was also reported in chronic alcohol consumption (Stibler et al. 1986; Stibler 1991) and hepatocellular carcinoma (Yamashita et al. 1989; Matsumoto et al. 1994) .
Tf also exists in cerebrospinal fluid (CSF), and CSF Tf is known to contain both sialo-and asialo-glycans (Hoffmann et al. 1995; Brown et al. 2012) . CSF Tfs are classified into two major isoforms Tf-1 and Tf-2 which are separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Futakawa et al. 2012) . Structural analysis revealed that Tf-1 has biantennary agalacto-complex-type glycan with bisecting GlcNAc and core α1,6-fucose whereas Tf-2 contains biantennary disialylated complex-type glycan. The Tf-2/Tf-1 ratio is raised in idiopathic normal pressure hydrocephalus, a dementia of the elderly caused by abnormal metabolism in the CSF (Futakawa et al. 2012) . Decreased asialotransferrin in CSF was also reported in patients with vanishing white matter disease characterized by deterioration of white matter in the brain (Vanderver et al. 2005) .
The range of glycoform variations of a single glycoprotein may be a factor in regulating molecular interactions governing cellular responses (Ohtsubo and Marth 2006) . Previous in vitro studies suggested that deglycosylation of Tf has no effect on iron binding or on receptor binding. However, changes in glycan structure of Tf alter its half-life in the circulation and affect iron transport in vivo (Hu et al. 1992) . To date, however, the influence of glycan structure on the biochemical properties of Tf has not been fully characterized. In order to clarify the glycoform-dependent properties, we here systematically performed comparative biochemical analyses of Tf-1, Tf-2 and sTf.
Experimental procedure Materials Human CSF was obtained by drainage during 3-5 days after neurosurgery, which was a part of routine post-operation treatment. The study was approved by ethics committees of Fukushima Medical University and RIKEN. Human sTf (holo form) was purchased from Sigma-Aldrich, and 1-anilino-8-naphthalene sulfonate (ANS) was purchased from Tokyo Chemical Industry, Co., Ltd. (Tokyo, Japan).
Purification of Tf-1 and Tf-2 from CSF CSF was initially filtered with PLANOVA 20N filter (Asahi Kasei Co. Ltd). The filtered CSF was concentrated to a volume of 150 mL by QuixStand Benchtop system (GE Healthcare) and dialyzed against 50 mM Tris-HCl, pH 8.5. The solution was then passed through Blue Sepharose 6 Fast Flow column (GE Healthcare) to remove albumin. The flow-through fraction was applied onto the anion-exchange SuperQ-650M column (TOYOPEARL) equilibrated with 50 mM Tris-HCl ( pH 8.5) and eluted with 30-75 mM NaCl. The eluant was passed through a protein G sepharose column (GE Healthcare) for the removal of IgG. The flow-through fraction was further applied onto a gel filtration HiLoad 10/300GL Superdex 200 column (GE Healthcare) equilibrated with 20 mM Tris-HCl ( pH 8.0) containing 100 mM NaCl and then an anion-exchange Mono Q column (GE Healthcare) using 50 mM Tris-HCl ( pH 8.5) with a linear gradient of NaCl concentration. The fractions corresponding to Tf-1 and Tf-2 were equilibrated with 20 mM Tris-HCl ( pH 8.0) containing 100 mM NaCl and concentrated to 4 mg/mL using an Amicon Ultra (molecular weight cutoff; 30K). The occupancy of Fe 3+ was estimated using the ratio of A 465 /A 280 (Klausner et al. 1983) , and both Tf-1 and Tf-2 were mostly the holo form. All procedures were performed at room temperature, and the samples were kept at 4°C until use. Column eluants were monitored by the absorbance at 280 nm.
Deglycosylation of transferrins with PNGase F
A hundred picomoles (8 μg) of purified Tfs were mixed with 250 units of PNGase-F (New England BioLabs) in a buffer containing 20 mM Tris-HCl ( pH 8.0) and 100 mM NaCl. The mixture was incubated at 37°C for 16 h, and the sample was subjected to SDS-PAGE, Blue native-PAGE and mass spectrometry analysis. For the complete removal of N-glycans, the samples were denatured prior to deglycosylation according to the previous report with a slight modification (Tarentino and Plummer 1994) . Tf samples were initially denatured by heating at 100°C for 10 min in the presence of 0.5% (w/v) SDS in 20 mM Tris-HCl ( pH 8.0) and 100 mM NaCl. After denaturation, 1% (v/v) NP-40 was added to the solution and deglycosylation was performed under the same conditions. The complete removal of N-glycans was checked by SDS-PAGE.
Blue native-PAGE analysis
Blue native-PAGE analysis of Tfs was performed according to the manufacturer's instructions using a Blue native gel electrophoresis kit (Invitrogen). Electrophoresis was performed at 150 V at 4°C until the blue dye reached the bottom of the gel. NativeMARK unstained marker (Invitrogen) was used as the standard protein. Protein bands were visualized by destaining the background using 8% (v/v) acetic acid solution.
Electrospray ionization mass spectrometry analysis Electrospray ionization mass spectrometry (ESI-MS) analyses of the transferrins were performed using a QSTAR ELITE quadrupole-time-of-flight mass spectrometer (AB Sciex, Foster City, CA) equipped with a Nanospray Tip (Humanix, Hiroshima, Japan). PNGase-F-treated and untreated Tf samples were desalted and concentrated using a self-made C8 (3M Empore high-performance extraction disks) Stage Tip. Eluted protein samples were dissolved in 70% (v/v) acetonitrile and 0.1% (v/v) formic acid to a concentration of 20 pmol/μL and directly transferred to the mass spectrometer. Observed masses were calibrated using a series of cluster ions derived from sodium trifluoroacetate. MS spectra were deconvoluted using Analyst QS software (AB Sciex).
LC-MS-MS analysis of trypsin-digested transferrin
Twenty micrograms of transferrin were denatured by 7 M guanidinium chloride, 50 mM Tris-HCl ( pH 8.5), 30 mM DTT and 10 mM EDTA at 37°C for 2 h and then alkylated with 3 mM 2-iodoacetamide. The reactant was dialyzed against 50 mM ammonium bicarbonate. Trypsin/LysC mix mass spec grade solution (Promega) was added to samples at a weight ratio of 1:25 and incubated at 37°C overnight. The resulting peptides were analyzed by using EASY-nLC 1000 HPLC system (Thermo Fisher Scientific, Inc., San Jose, CA) coupled with Q Exactive mass spectrometer (Thermo Fisher Scientific). The peptides were separated by NANO-HPLC capillary column, C18, 0.075 × 150 mm (Nikkyo Technos) using a gradient (0-48 min; 5-35% (v/v), 48-60 min; 35-65% (v/v) of acetonitrile in 0.1% (v/v) formic acid) at a flow rate of 0.3 μL/ min. The MS and MS/MS data were analyzed using Proteome Discover software (ver. 1.4) (Thermo Fisher Scientific Inc.) with the MASCOT search engine (ver. 2.4.1) (Matrix Science, London, UK).
Size-exclusion chromatography Tf-1 (11 μg) or Tf-2 (13 μg) was applied onto Superdex200 10/ 300 GL (GE Healthcare). The size-exclusion column was equilibrated with 10 mM sodium phosphate, pH 7.4, containing 150 mM NaCl at flow rate of 0.6 mL/min. Hen egg ovalbumin (43 kDa, 26.4 min), chicken egg white conalbumin (75 kDa, 25.2 min) and rabbit muscle aldolase (158 kDa, 23.4 min) were used as molecular weight standard proteins.
Fluorescence correlation spectroscopy Fluorescence labeling of Tf was performed using Alexa Fluor 488 succinimidyl esters (NHS esters, Life Technologies). Briefly, 5 μg of each of the forms of Tf dissolved in 10 μL of 0.1 M NaHCO 3 was mixed with 1 μL of 200 μM Alexa Fluor 488 NHS esters dissolved in N,N-dimethylformamide at room temperature for 1 h with continuous mixing. The reaction mixture was desalted and concentrated by Vivaspin 500-10K (GE Healthcare, Japan). Hydrodynamic radius of Tf in PBS was estimated from the best-fit diffusion time obtained by fluorescence correlation spectroscopy (FCS) measurements as described previously (Nagaya et al. 2008 ). The analyses indicated that one-component 3D diffusion model sufficiently explained the autocorrelation function of all the FCS measurements (χ 2 < 1 × 10 −4 ). The well-established hydrodynamic radius of Rhodamine 6G (0.6 nm) was used as a reference (Gendron et al. 2008 ).
Measurements of ANS fluorescence spectra Fluorescence spectra of ANS were recorded on a Hitachi F-4500 spectrofluorometer using a 3-mm cuvette at 25°C. A solution of Tf-1 (2 μM) dissolved in PBS (8 mM Na 2 HPO 4 , 1 mM KH 2 PO 4 , 137 mM NaCl and 3 mM KCl, pH 7.4) was mixed with 140 μM ANS and then incubated for 10 min. The excitation wavelength was set to 390 nm and emission spectra were recorded at 1-nm intervals from 400 to 600 nm using slit widths of 5 nm for both excitation and emission.
Estimation of polypeptide-glycan contact surface of transferrins The coordinate of human transferrin harboring sialylated biantennary N-glycans (Structure A) was obtained from the crystal structure of TbpA-transferrin complex (PDB code 3V8X) (Noinaj et al. 2012) . In order to evaluate the effect of N-glycan on the solvent accessibility of the protein surface, we generated a model of the human transferrin structure, in which a single GlcNAc is attached onto Asn432 by simply trimming the other carbohydrate residues while the Asn630-glycan remains intact (Structure B). For the two structures, the contact area between Asn432-glycan and protein was calculated using AREAIMOL (Lee and Richards 1971) . In the program, the contact area (Å 2 ) is calculated by subtraction of solvent-accessible surface areas between glycosylated and non-glycosylated transferrins.
Results
Purification of Tf-1 and Tf-2 from human CSF Tf-1 and Tf-2 were purified from human CSF through several steps of column chromatography and separated by the final anion-exchange chromatography step (see Experimental procedure). The first and second peaks were assigned as Tf-1 and Tf-2, respectively, based on previous results (Futakawa et al. 2012) . Tf-1 and Tf-2 each produced a single discrete band at 66-73 kDa on SDS-PAGE under non-reducing conditions. The mobility of Tf-2 is almost identical to that of sTf, while Tf-1 moves slightly faster (Figure 2A ). PNGase-F treatment under non-denaturing conditions increases the mobility of all three samples. Importantly, PNGase-F treatment of the heat-denatured transferrins in the presence of SDS showed further increases in the mobility of all three samples. These observations indicate that one of the two N-glycans is relatively inaccessible to PNGase F and can be released only after heat denaturation in the presence of SDS.
The native molecular sizes of sTf, Tf-1 and Tf-2 ( Figure 2B ) were assessed by Blue native PAGE. The mobilities of sTf and Tf-2 are almost identical and correspond to an apparent molecular mass of 230 kDa. Tf-1 has a markedly different mobility corresponding to 340 kDa. PNGase-F treatment under nondenaturing conditions increases the mobility of Tf-1 and decreases those of sTf and Tf-2. The latter bands correspond to 290 kDa. Evidently, glycan structure influences protein mobility in Blue native PAGE in unpredictable ways that upset the normal relation between mobility and molecular mass. It can be concluded, though, that the glycan structures of Tf-2 and sTf are very similar or identical, while that of Tf-1 is different.
LC-MS-MS analysis of glycopeptides derived from Tf-1 and Tf-2
We next examined the structures of the N-glycan at each glycosylation site. Trypsin-digested Tf-1 and Tf-2 fragments were Exposure of hydrophobic surface on transferrin subjected to LC-MS-MS analyses, and we identified the glycopeptides containing Asn432 or Asn630. The results are summarized in Table I . Four masses were identified for the Asn432-containing glycopeptide (CGLVPVAENYNK) in Tf-1, and the glycan composition can be assigned as (HexNAc) 1 , (Hex) 5 (HexNAc) 2 , (Hex) 3 (HexNAc) 5 and (Hex) 3 (HexNAc) 6 . In conjunction with the MS/MS data (Supplementary data, Figure S1 -S3) and previous reports (Hoffmann et al. 1995; Futakawa et al. 2012) , the latter three glycans are identified as Man 5 GlcNAc 2 , Man 3 GlcNAc 5 and Man 3 GlcNAc 6 . An interesting feature is the existence of a HexNAc monosaccharide residue in the Asn432-containing glycopeptides, and the MS/ MS data ( Figure 3A ) point to it being GlcNAc. In Tf-2, only one mass was observed for the Asn432-containing glycopeptide, and the glycan composition is assigned as (Hex) 5 (HexNAc) 4 (NeuAc) 2 (Supplementary data, Figure S4 ). In conjunction with the previous report (Futakawa et al. 2012 ), the structure is predicted to be disialylated biantennary glycan (NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-6[NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-3]Manβ1-4GlcNAcβ1-4GlcNAc). In contrast to the heterogeneity on Asn432, the N-glycans on Asn630 are quite uniform in both Tf-1 and Tf-2. In Tf-1, the Asn630-glycan contains five HexNAc, three Hexose and one deoxyhexose (Table I, Figure 3B ), which can be assigned as GlcNAc-terminated complex-type N-glycan bearing bisecting GlcNAc with proximal fucose (GlcNAcβ1-2Manα1-6 [GlcNAcβ1-2Manα1-3][GlcNAcβ1-4]Manβ1-4GlcNAcβ1-4[Fucα1-6] GlcNAc) as observed previously (Futakawa et al. 2012 ). In 
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Tf-2, the Asn630-glycan is the same as on Asn432, namely (Hex) 5 (HexNAc) 4 (NeuAc) 2 (Supplementary data, Figure S5 ) assigned as disialylated biantennary glycan (NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-6 [NeuAcα2-6Galβ1-4GlcNAcβ1-2Manα1-3]Manβ1-4GlcNAcβ1-4GlcNAc). Thus Tf-1 is heterogeneous, exhibiting at least four glycoforms, all associated with Asn432, while Tf-2, as we isolated it, is homogeneous with identical glycan on the two Asn.
Mass spectrometric analyses of intact Tf-1 and Tf-2 In order to estimate the ratio of each glycoform, we investigated the total mass of Tf-1 and Tf-2 by ESI-mass spectrometry. Ionization efficiency of intact proteins is governed by the charges on the polypeptide, thus accurate quantification of each glycoform is possible. The deconvoluted spectrum of intact Tf-1 gave four major peaks at 78,502, 78,298, 78,014 and 76,999 Da with relative amounts of 17, 52, 24 and 7%, respectively ( Figure 4A ). Our LC-MS-MS analyses allowed all four peaks to be assigned as summarized in Table II . This is consistent with previous data, in which PNGase-F treatment of Tf-1 liberates the GlcNAc-terminated biantennary N-glycan with bisecting GlcNAc and core fucose (Futakawa et al. 2012) .
In contrast to Tf-1, the mass spectrum of intact Tf-2 presents a single ion at 79,562 Da ( Figure 4B ), which corresponds closely to the average mass of transferrin with two disialylated biantennary glycans (79,569 Da). The mass spectrum of PNGase-F-treated Tf-2 under non-denaturing conditions also shows a single peak at 77,355 Da-a mass difference of 2207 Da compared with the untreated protein, which corresponds to one disialylated biantennary glycan. The total mass analyses are consistent with our peptide analyses. It is known that most of sTf is modified with a disialylated biantennary sugar chain Fig. 4 . Mass spectrometric analyses of transferrins for the determination of each glycoform ratio. (A) Deconvoluted ESI-MS mass spectra of intact Tf-1 (upper) and PNGase F-treated Tf-1 under non-denaturing conditions (lower). (B) Deconvoluted ESI-MS mass spectra of intact Tf-2 (upper) and PNGase F-treated Tf-2 under non-denaturing conditions (lower). Peak assignments are shown schematically for each mass peak. The glycoforms were deduced from the present MS data and previous reports (Hoffmann et al. 1995; Futakawa et al. 2012) . (Spik et al. 1975; Dorland et al. 1977; März et al. 1982; Spik et al. 1988) , and this would fit with Tf-2 being identical to the major glycoform of sTf. We hereafter assume that Tf-2 and sTf are equivalent.
Estimation of apparent molecular size of Tf-1 and Tf-2 According to Blue native PAGE, the mobilities of Tf-1 and Tf-2 are significantly different. In order to check the molecular sizes of Tf-1 and Tf-2 in solution, we first performed size-exclusion chromatography analysis. Both Tf-1 and Tf-2 gave a single peak eluting at 24.6 min, whereas Tf-1 eluted later at 25.0 min ( Figure 5A ). The molecular masses of the two Tfs are estimated to be 100 and 116 kDa, respectively, assuming that their shapes are globular. This suggests that both Tf-1 and Tf-2 are monomers in solution but have significantly different apparent molecular sizes.
The hydrodynamic radii of the transferrins in solution were further assessed by FCS analysis (Supplementary data, Figure S6 ). The hydrodynamic radius of Tf-1 was calculated to be 4.6 nm, while that of sTf was 5.2 nm ( Figure 5B ). These results qualitatively agree with the size-exclusion chromatography data. Given that the crystal structures of the two polypeptide chains are very similar, the size differences found in both analyses can be ascribed to structural differences in glycan structure.
Surface hydrophobicity of Tf-1 and Tf-2 probed by ANS fluorescence Glycosylation may stabilize proteins by providing a surface cover through intramolecular glycan-polypeptide interactions (Wyss et al. 1995; Mer et al. 1996) . We hypothesized that an alteration in glycan structure in transferrin, evident in the altered molecular sizes and hydrodynamic radii of Tf-1 and Tf-2/sTf, may expose protein surface and possibly induce a conformational change in the polypeptide. To clarify this, we first performed X-ray crystallographic analysis of Tf-1. However, we found that the conformation of the polypeptide main chain (data not shown) was very similar to a previously reported sTf structure (PDB code 3V83, Noinaj et al. 2012 ). We then examined the surface properties of Tf-1 and Tf-2 using the fluorescent probe ANS, which has been widely used to monitor conformational transitions in proteins owing to its affinity for partially exposed hydrophobic regions (Stryer 1965; Hawe et al. 2008 ). Addition of Tf-1 to an ANS solution induced a marked enhancement of fluorescence, with a maximum at 492 nm ( Figure 6 ). In contrast, ANS showed only weak fluorescence with sTf at 504 nm. ANS alone showed weak fluorescence at 508 nm. The strong, red-shifted fluorescence of ANS in the presence of Tf-1 suggests that it binds to an exposed hydrophobic surface or pocket of the Tf-1 polypeptide, which is covered in sTf.
Estimation of glycan-protein contact area of transferrin
In order to investigate the coverage of transferrin surface by N-glycans, we calculated the glycan-protein contact surface area. We analyzed two coordinates of transferrins: one is the crystal structure of serum human transferrin in complex with TbpA, in which the electron densities of two sialylated biantennary N-glycans were clearly observed. The other is generated from the first model, in which the single GlcNAc is attached on Asn432. The first model (Structure A) is considered as sTf/Tf-2, whereas the second model (Structure B) is taken as one of the Tf-1 glycoforms. The effect of glycan trimming at Asn432 was evaluated by calculating the contact area between protein and glycans (Table III) . In Structure A, several hydrophobic residues (Ala443, Gly444, Phe446 and Ala594), which are adjacent to Asn432, contact the glycan. In contrast, these hydrophobic residues become exposed to solvent in Structure B, which bears only the single GlcNAc at Asn432 (Figure 7 ).
Discussion
In this study, we have investigated relationships between glycan structure and biochemical characteristics of transferrin purified from human CSF. Two isoforms of transferrin, Tf-1 and Tf-2, were isolated and their glycan structure on each of the two glycosylation sites, Asn432 and Asn630, identified. We found that Tf-1 was heterogeneous due to four glycoforms in the carbohydrate chain on Asn432, whereas Tf-2 was homogeneous and Average masses calculated using the UniProt sequence data (P02787) assuming the presence of 19 disulfide bridges within it. In the PNGase F-treated samples, the theoretical masses are calculated assuming that one N-glycosylated Asn residue is converted to Asp.
Exposure of hydrophobic surface on transferrin the two asparagines were derivatized with the same disialylated biantennary glycan. The results in this regard are consistent with previous studies (Hoffmann et al. 1995; Brown et al. 2012) . We found that the N-glycan attached on Asn630 is PNGase-F sensitive, while that on Asn432 is resistant irrespective of the glycan structure. According to crystal structures, the Asn432 side chain is partially buried inside the protein, while that of Asn630 is exposed to solvent, which may explain the cleavage preferences (Figure 7) . A unique feature of our findings is that there is a significant population of Tf-1 tranferrins with a single HexNAc residue attached to Asn432 ( Figure 3A ). This could either be the result of the action of an endogenous or exogenous endoglycosidase. There is one report of an endo-β-N-acetylglucosaminidase (ENGase) in humans, which may be involved in the processing of free oligosaccharides in the cytosol (Suzuki et al. 2002) . However, the topology and localization of Tf-1 in the secretory pathway may prevent the ENGase reaction. There is the possibility through that membrane-disordered or apoptotic cells in certain pathological conditions release cytosolic ENGase to CSF. An exogenous enzyme may originate from bacteria contaminating CSF. Endoglycosidases have been identified in a number of Gram-positive pathogens, including Streptococcus pneumoniae (Clarke et al. 1995) , Streptococcus pyogenes (Collin and Olsén 2001) and Enterococcus faecalis (Roberts et al. 2000; Collin and Fischetti 2004) . Interestingly, such cleavage of N-glycan has been identified in the Asn-X-Ser/Thr sequon of fungi which also yields a single N-GlcNAc (Hase et al. 1982) , and the findings have been extended to both plants and animals (Chalkley et al. 2009; Kim et al. 2013 ). Evidence appears to be accumulating that a single N-GlcNAc residue on asparagines in glycoproteins may have physiological relevance. It warrants further study. The contact areas were calculated using AREAIMOL (Lee and Richards 1971) , for the human transferrin structure (PDB code 3V8X) with sialylated biantennary glycan (Structure A) and with single GlcNAc (Structure B) attached to Asn432. The residue which shows a different contact area between Structures A and B is listed. Among them, hydrophobic residues are indicated with asterisks and are highlighted in yellow (Figure 7) . Figure S6 . The best-fits were directly converted to Stokes-Einstein hydrodynamic radius using that of rhodamine 6G as a reference.
The hydration volume of Tf-1 is slightly smaller than that of Tf-2 as indicated by size-exclusion chromatography and FCS analysis ( Figure 5 ). It is plausible that the two disialylated biantennary glycans of Tf-2 are rather spread out as a consequence of the negatively charged sialic acid residues and electrostatic repulsion. The neutral N-glycans on Tf-1 may allow for a more compact shape. Further, ANS fluorescence indicated that the probe binds to a hydrophobic patch or pocket on Tf-1, according to the marked increase in red-shifted fluorescence, but not on Tf-2 ( Figure 6 ). There are a number of hydrophobic patches in the vicinity of Asn432 and Asn630 as seen in a map of hydrophobic residues on human sTf with two sialylated biantennary glycans on Asn432 and Asn630 (Figure 7) . Evidently, the spread nature of the disialyl biantennary glycans of Tf-2, their negative charge, and their bulkiness, prevent binding of ANS to the polypeptide, whereas access is gained in the case of Tf-1. The single GlcNAc at Asn432 is probably particularly significant, as the antennary glycans normally cover several hydrophobic patches around this asparagine (Table III, Figure 7) . Interestingly, Tf significantly inhibits Aβ self-association by directly binding to Aβ oligomers (Raditsis et al. 2013) . Although the Aβ-binding site on Tf is unknown, it is plausible that an exposed hydrophobic surface on Tf-1 is involved. Tf-binding proteins from Neisseria, human pathogens causing bacterial meningitis, extract iron ion through the binding of C-lobe of sTf (Noinaj et al. 2012) . Since the binding interface is sandwiched between Asn432 and Asn630, the difference of glycoform at these sites may affect the virulence of the bacteria.
How glycan structure might affect the physiological properties of glycoproteins has been the subject of study over a long period. The relationship between loss of glycan and severity of CDG has received particular attention through investigation of sTfs. N-Glycan is lost at each glycosylation site in patients with CDG-I (Yamashita et al. 1993 ) and chronic alcohol abuse (Henry et al. 1999) . N-Glycan occupancy of Asn630 appears to be slightly lower than Asn432 in CDG-I patients and the deficiency correlates with the severity of the CDG-I condition (Hülsmeier et al. 2007 ). The efficiency of site-specific N-glycosylation remains an issue of debate, however our findings on transferrin glycoforms, wherein an alteration in glycan structure changes the hydrodynamic properties and surface exposure of hydrophobic patches, may have relevance in understanding CDG pathology.
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